Salidroside alleviates oxidative stress in dry eye disease by activating autophagy through AMPK-Sirt1 pathway

In conclusion, our data suggest that salidroside is a promising candidate for DED treatment.PMID:37302369 | DOI:10.1016/j.intimp.2023.110397

Source: International Immunopharmacology - June 11, 2023 Category: Allergy & Immunology Authors: Qi Liang Rongjie Guo Jia-Ruei Tsao Yun He Chenchen Wang Jiaxuan Jiang Di Zhang Taige Chen Tingting Yue Kai Hu Source Type: research